کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
3854072 | 1598547 | 2012 | 4 صفحه PDF | دانلود رایگان |

SummaryMalignancy is considered to be the third most common cause of death in renal transplant recipients. The etiology of posttransplantation malignancy seems to be multifactorial. This report describes a rare case of astrocytoma following renal transplantation. We encountered a 28-year-old man who presented with a 20-day history of headache, vomiting, and blurred vision prior to admission. The patient was diagnosed with end-stage renal disease and underwent two renal transplantations at 8 and 2 years prior, respectively. Examination of the cerebrospinal fluid revealed a predominant lymphocytic pattern and increased protein levels. Brain imaging showed two separate ill-defined hypodense lesions. The patient underwent a stereotactic brain biopsy, from which the tumor was classified as a histological grade II astrocytoma. He received a course of radiotherapy treatments and his condition improved. The systematic screening of renal transplant recipients for cancer should be performed in order to enable early intervention when necessary.
癌症是腎臟移植接受者的第三大死因,其發生可能歸因於多方面的因素。本個案是一位28歲的男性,於接受腎臟移植後罕有的出現星狀細胞瘤。病人分別於8及2年前先後接受兩次腎臟移植,而在本次住院前20日,病人開始出現頭痛、嘔吐及視覺模糊等症狀。腦脊髓液分析顯示淋巴球為主及蛋白質增多的現象,腦部造影則發現兩個分開且邊緣模糊的低密度病灶。立體定位腦部切片顯示病灶屬於WHO組織學第II級星狀細胞瘤。病人在接受了放射線療法後呈現持續改善。本個案說明了,腎臟移植接受者應及早接受癌症篩檢,以利治療的有效實施。
Journal: Hong Kong Journal of Nephrology - Volume 14, Issue 2, October 2012, Pages 54–57